Haley Danielle F, Bullington Brooke W, Tien Phyllis, Knittel Andrea K, Bobitt Julie, Kempf Mirjam-Colette, Philbin Morgan, Hanna David B, Lindsey StarrLa'diamond, Kassaye Seble, DeHovitz Jack, Cohen Mardge, Wingood Gina, Jones Deborah L, Williams Michael P, Wang Richard J, Edmonds Andrew
Department of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Avenue, Boston, MA, 02118, USA.
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
AIDS Behav. 2025 Jun;29(6):2022-2032. doi: 10.1007/s10461-025-04669-z. Epub 2025 Mar 7.
Cannabis legalization in the United States changed cannabis product potency and consumption modalities. Women with HIV are an aging population with prevalent cannabis use twice that of national estimates. Because cannabis use may confer both health benefits and risks, it is important to understand cannabis use patterns among women with HIV. This analysis characterized prevalence, frequencies, and modes (smoking, vaping, eating) of cannabis use among 1,246 women with HIV in the Women's Interagency HIV Study over 18 months (2018-2019). We compared participant characteristics using chi-square tests and Wilcoxon rank-sum tests. We illustrated flow between cannabis use frequency categories with a Sankey diagram. Median participant age was 52 years (interquartile range: 46, 58). 65% of participants identified as Black/African American; 50% had annual household incomes <$12,000. The period prevalence was 27% for any cannabis use and 15% for daily or more use. 50% reported varying use frequencies. Among women using cannabis, 96% reported smoking, 30% consumed edibles, and 18% vaped. Compared with women not using cannabis, greater proportions of women using cannabis reported alcohol (69% vs. 37%, p < 0.01), cigarette (61% vs. 29%, p < 0.01) and other drug use (16% vs. 4%, p < 0.01). Compared to those with no high potency use, a higher proportion of women using high potency products were in a state legalizing cannabis sales. Cannabis use among women with HIV is common and of variable frequency. Future work should characterize patterns of use, product choice motivations, and associated health impacts in the context of aging and HIV.
美国大麻合法化改变了大麻产品的效力和消费方式。感染艾滋病毒的女性是一个老龄化群体，其大麻使用率是全国估计水平的两倍。由于使用大麻可能带来健康益处和风险，了解感染艾滋病毒女性的大麻使用模式很重要。这项分析描述了在18个月（2018 - 2019年）期间，女性机构间艾滋病毒研究中1246名感染艾滋病毒女性的大麻使用流行率、频率和方式（吸烟、吸电子烟、食用）。我们使用卡方检验和威尔科克森秩和检验比较了参与者特征。我们用桑基图展示了大麻使用频率类别之间的流动情况。参与者的年龄中位数为52岁（四分位间距：46，58）。65%的参与者为黑人/非裔美国人；50%的家庭年收入低于12,000美元。任何大麻使用的期间流行率为27%，每天或更多使用的流行率为15%。50%的人报告使用频率不同。在使用大麻的女性中，96%报告吸烟，30%食用大麻食品，18%吸电子烟。与不使用大麻的女性相比，使用大麻的女性中报告饮酒（69%对37%，p < 0.01）、吸烟（61%对29%，p < 0.01）和使用其他药物（16%对4%，p < 0.01）的比例更高。与不使用高效力产品的女性相比，使用高效力产品的女性中处于大麻销售合法化州的比例更高。感染艾滋病毒女性中的大麻使用很常见且频率各异。未来的工作应在老龄化和艾滋病毒背景下描述使用模式、产品选择动机及相关健康影响。
